DHR vs PLTR: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Palantir Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Palantir Technologies Inc. · Technology
$142.76
-24.3% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
PLTR |
| Current Price |
$174.04 |
$142.76 |
| Fair Value Estimate |
$197.01 |
$108.00 |
| Upside to Fair Value |
+13.2%
|
-24.3%
|
| Market Cap |
$123.2B |
$327.1B |
| Forward P/E |
33.4x
|
209.7x
|
| EV / EBITDA |
20.3x
|
—
|
| Price / Sales |
5.0x
|
73.1x
|
| Price / FCF |
23.3x
|
155.7x
|
| Revenue Growth YoY |
+3.7%
|
+19.1%
|
| Gross Margin |
60.7%
|
82.4%
|
| Operating Margin |
21.0%
|
31.6%
|
| Return on Equity |
7.1%
|
25.7%
|
| Dividend Yield |
0% |
— |
| FCF Yield |
4.3%
|
0.6%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Palantir Technologies develops data analytics and AI software platforms like Gotham and Foundry for government and commercial clients. The business excels with high margins (gross 82.4%, net 36.3%), accelerating growth (Q4 FY2025 revenue up 70% YoY to $1.41B, 2026 guidance $7.19B implying 61% growth), and strong moats in defense and enterprise AI, but trades expensively at 73x P/S versus 5-year m…
Accumulation Zones
| Metric |
DHR |
PLTR |
| Zone Low |
$147.76 |
$81.00 |
| Zone High |
$167.46 |
$92.00 |
| In Buy Zone? |
No
|
No
|